Andes, an Emeryville, CA-based agriculture and biotechnology company, raised USD15m in Series A funding.
The round was co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Cavallo Ventures, with participation from new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini and existing investors KdT Ventures and Endurance.
The company intends to use the funds to scale its self-sustaining, nitrogen-fixing seeds across the U.S. market, expand into South America, and to advance further research and development into its complementary nature-based permanent carbon capture technology.
Led by Gonzalo Fuenzalida, CEO, Andes develops biological solutions enabling positive action for fighting climate change. Its first generation of solutions focus on the agricultural industry. Through its novel microbial seed treatment technology called Microprime, the company reduces the need for synthetic fertilizers and enables the seed to draw down nitrogen from the air. Andes is also developing microbes for plant roots and can create nature-based permanent carbon capture solutions to sequester and store CO2 from the atmosphere into the soil.
FinSMEs
17/09/2021